Effect of Pharmacist Provided Drug Information Services After Hospital Discharge

NCT03829995 | Completed DMC

• 1 other identifier: H-18003889
• Study Type: interventional
• Target: 250
• Locations: 1 country
• Sites: 1

Brief Summary

Objective: The aim of this study is to evaluate if offering drug counseling from a hospital pharmacy increases patient satisfaction and sense of security regarding drug treatment after hospital discharge.

Conditions

Drug Counseling

Outcome Measures

Primary Outcomes (1)

• Sense of security regarding drug treatment and satisfaction with drug counseling.

  The questionnaire comprised closed-ended questions, open-ended questions and questions or statements where the respondents were asked to rate the questions or statements on a five-point scale. The scale used is a attitude measurement scale that assess attitudes by presenting respondents with sentences that state beliefs about the particular attitude being measured. The respondents then decide to what extent he or she agrees with the statement. The responses are divided numerically into a series of ordered responses. Ratings: 1 = not at all, 2 = to a small extent, 3 = to some extent, 4 = to a great extent, 5 = to a very great extent.

  2-4 weeks after discharge.

Secondary Outcomes (7)

• Number of medications by admission.

  Within one week after discharge.

• Number of medications by discharge.

  Within one week after discharge.

• Number of patients that received medication review by pharmacist during admission.

  Within one week after discharge.

• Number of patients that received help with medication at home after discharge.

  Within one week after discharge.

• Number of enquiries.

  Directly after the patient received drug counseling.

Study Arms (2)

Control group

NO INTERVENTION

Participants in the control group received the normal care following the Danish standard procedure.

Intervention group

ACTIVE COMPARATOR

Participants in the intervention group received the normal care following the Danish stadard procedure. Additionally the participants was also offered the possibility to contact a hospital pharmacy department by phone or mail for drug counseling.

Other: Drug counseling

Interventions

Drug counseling OTHER

Participants can contact a hospital pharmacy department by phone or mail and ask questions regarding drug-related issues.

Intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients discharged from the acute medical ward and department of respiratory medicine at Bispebjerg Hospital.
• Patients discharged to own home.
• Can speak the danish language.
• ≥18 years old.
• Can be contacted by phone.

You may not qualify if:

• Cognitive and communicative problems (e.g. dementia, aphasia, suicidal) or other barriers that unable the participant to use the intervention service.
• Patient does not answer phone within five attempts on five different days, when trying to conduct patient interview.
• Cognitive and communicative problems that unable the participant to answer questions in the patient interview.
• Deceased or readmitted before patient interview.

Sponsors & Collaborators

• Region Hovedstadens Apotek: lead
• The Hospitals Pharmacies' and Amgros' Research Development Foundation: collaborator

Study Sites (1)

Capital Regions Hospital Pharmacy

Copenhagen, København NV, 2400, Denmark

Location

Related Publications (1)

• Fjaere KW, Vejborg TE, Colberg L, Ulrich CS, Pedersen L, Demeny AK, Poulsen JH, Armandi HB, Clemmensen MH. Medicine information helpline after hospitalization-a randomized trial: Impact on patient satisfaction, patient concerns about medicines and clinical outcome on patient safety. PLoS One. 2023 Oct 26;18(10):e0293523. doi: 10.1371/journal.pone.0293523. eCollection 2023.

  PMID: 37883413 DERIVED

Study Officials

• Tim E Vejborg, M.Sc.Pharm

  Region Hovedstadens Apotek

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: The study is a open-label trial. The pharmacist know, whether the patient is randomized to the intervention group or the control group.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: The intervention group is compared with the control group.

Study Record Dates

• First Submitted: January 22, 2019
• First Posted: February 4, 2019
• Study Start: July 12, 2018
• Primary Completion: June 3, 2019
• Study Completion: June 3, 2019
• Last Updated: June 5, 2019

Record last verified: 2019-06

Locations

DK (1)